# Arts Way Manufacturing Co Inc: overview ARTW · Nasdaq · CIK 7623 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30 Pages: [Overview](/companies/artw.md) · [Financials](/companies/artw/financials.md) · [Filings](/companies/artw/filings.md) · [Insiders](/companies/artw/insiders.md) Latest reported revenue: [$5.6m](/filings/0001437749-26-032521.md) for Q3 FY2026, three months to 2026-08-31, from the 10-Q filed Oct 13, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-032521). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,170 d](/filings/0001437749-26-003904.md) | [5,141](/filings/0001437749-26-012161.md) | [6,337](/filings/0001437749-26-023597.md) | [6,432](/filings/0001437749-26-032521.md) | [5,065 d](/filings/0001437749-26-003904.md) | [6,640](/filings/0001437749-26-012161.md) | [7,854](/filings/0001437749-26-023597.md) | [5,615](/filings/0001437749-26-032521.md) | | Gross margin | % | [36.1% d](/filings/0001437749-26-003904.md) | [29.1%](/filings/0001437749-26-012161.md) | [32.5%](/filings/0001437749-26-023597.md) | [27.5%](/filings/0001437749-26-032521.md) | [18.6% d](/filings/0001437749-26-003904.md) | [28.8%](/filings/0001437749-26-012161.md) | [25.9%](/filings/0001437749-26-023597.md) | [29.6%](/filings/0001437749-26-032521.md) | | Operating margin | % | [8.4% d](/filings/0001437749-26-003904.md) | [0.0%](/filings/0001437749-26-012161.md) | [8.1%](/filings/0001437749-26-023597.md) | [5.4%](/filings/0001437749-26-032521.md) | [(11.2%) d](/filings/0001437749-26-003904.md) | [5.0%](/filings/0001437749-26-012161.md) | [3.6%](/filings/0001437749-26-023597.md) | [(1.2%)](/filings/0001437749-26-032521.md) | | Net margin | % | [13.5% d](/filings/0001437749-26-003904.md) | [(1.1%)](/filings/0001437749-26-012161.md) | [23.4%](/filings/0001437749-26-023597.md) | [4.0%](/filings/0001437749-26-032521.md) | [(12.7%) d](/filings/0001437749-26-003904.md) | [3.0%](/filings/0001437749-26-012161.md) | [2.2%](/filings/0001437749-26-023597.md) | [(2.5%)](/filings/0001437749-26-032521.md) | | Diluted EPS | $ per share | not reported | [(0.01)](/filings/0001437749-26-012161.md) | [0.29](/filings/0001437749-25-022639.md) | [0.05](/filings/0001437749-26-032521.md) | not reported | [0.04](/filings/0001437749-26-012161.md) | not reported | [(0.03)](/filings/0001437749-26-032521.md) | | Free cash flow | $k | [1,086 d](/filings/0001437749-26-003904.md) | [(185)](/filings/0001437749-26-012161.md) | [1,223 d](/filings/0001437749-26-023597.md) | [(1,529) d](/filings/0001437749-26-032521.md) | [(1,042) d](/filings/0001437749-26-003904.md) | [(28.0)](/filings/0001437749-26-012161.md) | [21.4 d](/filings/0001437749-26-023597.md) | [12.9 d](/filings/0001437749-26-032521.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-11-30) | FY2023 (2023-02-28) | FY2023 (2023-11-30) | FY2024 (2024-11-30) | FY2025 (2025-11-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [25.6](/filings/0001437749-24-005855.md) | not reported | [30.3](/filings/0001437749-25-004172.md) | [24.5](/filings/0001437749-26-003904.md) | [23.0](/filings/0001437749-26-003904.md) | | Gross margin | % | [27.1%](/filings/0001437749-24-005855.md) | not reported | [28.3%](/filings/0001437749-25-004172.md) | [29.8%](/filings/0001437749-26-003904.md) | [27.3%](/filings/0001437749-26-003904.md) | | Operating margin | % | [2.4%](/filings/0001437749-24-005855.md) | not reported | [5.1%](/filings/0001437749-25-004172.md) | [1.9%](/filings/0001437749-26-003904.md) | [1.3%](/filings/0001437749-26-003904.md) | | Net margin | % | [0.4%](/filings/0001437749-24-005855.md) | not reported | [0.9%](/filings/0001437749-25-004172.md) | [1.3%](/filings/0001437749-26-003904.md) | [4.5%](/filings/0001437749-26-003904.md) | | Diluted EPS | $ per share | [0.02](/filings/0001437749-24-005855.md) | [0.07](/filings/0001437749-23-010158.md) | [0.05](/filings/0001437749-25-004172.md) | [0.06](/filings/0001437749-26-003904.md) | [0.20](/filings/0001437749-26-003904.md) | | Free cash flow | $m | [(0.7)](/filings/0001437749-24-005855.md) | not reported | [(0.9)](/filings/0001437749-25-004172.md) | [1.9](/filings/0001437749-26-003904.md) | [(1.5)](/filings/0001437749-26-003904.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/artw/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $352.6k | 134,074 | | Reduced −7,400 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $124.6k | 47,384 | | Added +34,839 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $124.4k | 47,306 | | Added +2,627 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $90.5k | 34,422 | | Unchanged | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $66.3k | 25,200 | | Added +2,000 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $61.0k | 23,194 | | Unchanged | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $51.7k | 19,664 | | Added +8,079 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $41.3k | 15,690 | | Added +729 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $31.8k | 12,077 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $27.7k | 10,540 | | Added +2,240 | ## Recent filings [All 755 filings](/companies/artw/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 16:17 ET | [10-Q](/filings/0001437749-26-032521.md) | Quarterly report, period 2026-08-31 | 0001437749-26-032521 | | 2026-10-09 | 17:05 ET | [8-K](/filings/0001437749-26-032423.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-032423 | | 2026-08-10 | 19:37 ET | [8-K](/filings/0001437749-26-026761.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-026761 | | 2026-07-15 | 15:21 ET | [10-Q](/filings/0001437749-26-023597.md) | Quarterly report, period 2026-05-31 | 0001437749-26-023597 | | 2026-07-10 | 14:04 ET | [8-K](/filings/0001437749-26-023255.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-023255 | | 2026-06-29 | 22:50 ET | [8-K](/filings/0001437749-26-021876.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-021876 | | 2026-04-22 | 18:40 ET | [8-K](/filings/0001437749-26-013019.md) | 5.07 Shareholder vote results | 0001437749-26-013019 | | 2026-04-13 | 20:19 ET | [10-Q](/filings/0001437749-26-012161.md) | Quarterly report, period 2026-02-28 | 0001437749-26-012161 | | 2026-04-09 | 18:38 ET | [8-K](/filings/0001437749-26-011878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-011878 | | 2026-03-12 | 18:30 ET | [DEF 14A](/filings/0001437749-26-007917.md) | Proxy statement, period 2026-04-21 | 0001437749-26-007917 | ## Latest annual report [Form 10-K for the fiscal year ended Nov 30, 2025](/filings/0001437749-26-003904.md), filed Feb 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 7623 - Tickers: ARTW - Exchange: Nasdaq - SIC code: 3523 Farm Machinery & Equipment - State of incorporation: NC - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.